Abstract
The isolation of caffeine from green coffee beans was described in Germany in 1820 by Runge and confirmed the same year by von Giese. In France, Robiquet in 1823 and then Pelletier in 1826 independently discovered a white and volatile crystalline substance. The name “cofeina” appeared in 1823 in the “Dictionnaire des termes de médecine” and the word “caffein” or “Coffein” was used by Fechner in 1826. The same year, Martius discovered a substance which he called “guaranin”, and 1 year later a substance found in tea was named “thein” by Oudry. It was only in 1838 (Mulder; Jobst) and in 1840 (Martius; Berthemot and Dechastelus) that thein and guaranin respectively were shown to be identical with caffeine. In 1843 caffeine was found in maté prepared from Ilex paraguayensis (Stenhouse), and in 1865 in kola nuts (Daniell).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Albanese M (1895) Über das Verhalten des Caffeïns und des Theobromins im Organismus. Arch Exp Pathol Pharmakol 35: 449–466
Aldridge A, Neims AH (1979) The effect of phenobarbital and β-naphtolflavone on the elimination kinetics and metabolite pattern of caffeine in the beagle dog. Drug Metab Dispos 7: 378–382
Aldridge A, Neims AH (1980) Relationship between the clearance of caffeine and its 7-N-de-methylation in developing beagle puppies. Biochem Pharmacol 29: 1909–1914
Aldridge A, Parsons WD, Neims AH (1977) Stimulation of caffeine metabolism in the rat by 3-methylcholanthrene. Life Sci 21: 967–974
Aldridge A, Aranda JV, Neims AH (1979) Caffeine metabolism in the newborn. Clin Pharmacol Ther 25: 447–453
Aranda JV, Turmen T (1979) Methylxanthines in apnea of prematurity. Clin Perinatol 6: 87–108
Aranda JV, Louridas TA, Vitullo BB, Thorn P, Aldridge A, Haber R (1979) Metabolism of theophylline to caffeine in human fetal liver. Science 206: 1319–1321
Aranda JV, Turmen T, Sasyniuk BI (1980) Pharmacokinetics of diuretics and methylxanthines in the neonate. Eur J Clin Pharmacol 18: 55–63
Aranda JV, Beharry K, Kinlough L (1983) Development of caffeine biotransformation in humans (Abstr). Pediatr Res 17: 353
Arnaud MJ (1976 a) Identification kinetic and quantitative study of [2–14C] and [1-Me14C] caffeine metabolites in rat’s urine by chromatographic separations. Biochem Med 16: 67–76
Arnaud MJ (1976 b) Metabolism of 1,3,7-trimethyldihydrouric acid in the rat: new metabolic pathway of caffeine. Experientia 32: 1238–1240
Arnaud MJ (1980) Second international caffeine workshop. Nutr Rev 38: 197
Arnaud MJ (1981) Third international caffeine workshop. Nutr Rev 39: 183
Arnaud MJ (1983) Formation de dérivés de l’uracile au cours du métabolisme de la caféine. Med 5: 375–376
Arnaud MJ, Bracco I (1980) Fetal and early postnatal caffeine metabolism in the rat. World Conf Clin Pharm Ther, London, Abstract 0556
Arnaud MJ, Gétaz F (1982) Postnatal establishment of a bloodbrain barrier for theobromine in the rat. Experienta 38: 752
Arnaud MJ, Welsch C (1979 a) Metabolic pathway of theobromine in the rat and identification of two new metabolites in human urine. J Agric Food Chem 27: 524–527
Arnaud MJ, Welsch C (1979b) Metabolism of [1-Me14C]paraxanthine in the rat: identification of a new metabolite. Experientia 35: 34
Arnaud MJ, Welsch C (1980a) Caffeine metabolism in human subjetcs. In: IXth international colloquium in the sicence and technology of coffee, vol 1. Association Scientifique Internationale du Café, Paris, 1981, pp 385–396
Arnaud MJ, Welsch C (1980 b) Comparison of caffeine metabolism by perfused rat liver and isolated microsomes. In: Estabrook RW, Gelboni HV, Gilette JR, O’Brien PJ (eds) Microsomes, drug oxidations, and chemical carcinogenesis, Academic, New York, pp 813–816
Arnaud MJ, Welsch C (1981) Theophylline and caffeine metabolism in man. In: Rietbrock N, Woodcook BG, Staib AH (eds) Methods in clinical pharmacology, vol 3. Vieweg, Braunschweig Wiesbaden, pp 135–148
Arnaud MJ, Thélin-Dorner A, Ravussin E, Acheson KJ (1980) Study of the demethylation of [1,3,7-Me13C]caffeine in man using respiratory exchange measurement. Biomed Mass Spectrom 7: 521–524
Arnaud MJ, Braceo I, Welsch C (1982) Metabolism and distribution of labeled theophylline in the pregnant rat. Impairment of theophylline metabolism by pregnancy and absence of blood-brain-barrier in the fetus. Pediatr Res 16: 167–171
Arnaud MJ, Braceo I, Sauvageat JL, Clerc MF (1983) Placental transfer of the major caffeine metabolite in the rat using 6-amino-5[N-formylmethylamino]1,3[Me14C]-dimethyluracil administered orally or intravenously to the pregnant rat. Toxicol Lett 16: 271–279
Axelrod J, Reichenthal J (1953) The fate of caffeine in man and a method for its estimation in biological material. J Pharmacol Exp Ther 107: 519–523
Bada HS, Khanna NN, Somani SM, Tin AA (1979) Interconversion of theophylline and caffeine in newborn infants. J Pediatr 94: 993–995
Benedict SR (1916) Uric acid in its relation to metabolism. J Lab Clin Med 2: 1–15
Berthemot, Dechastelus (1840) Chemische Untersuchung des Guarana. Liebigs Ann Chem 36: 90–93
Birkett DJ, Grygiel JJ, Miners JO (1981) Metabolie disposition of the methylxanthines in man. In: Rietbrock N, Woodcock BG, Staib AH, (eds) Methods in clinical pharmacology, vol 3. Vieweg, Braunschweig Wiesbaden, pp 149–158
Bonati M, Latini R, Marzi E, Cantoni R, Belvedere G (1980) [2–14C] caffeine metabolism in control and 3-methylcholanthrene induced rat liver microsome by high pressure liquid chromatography. Toxicol Lett 7: 1–7
Bonati M, Latini R, Marra G, Assael BM, Parmi R (1981) Theophylline metabolism during the first month of life and development. Pediatr Res 15: 304–308
Bondzynski S, Gottlieb R (1895 a) Über Methylxanthin, ein Stoffwechselprodukt des Theobromins und Caffeïns. Ber Chem Ges 28: 1113–1118
Bondzynski S, Gottlieb R (1895 b) Über Methylxanthin, ein Stoffwechselprodukt des Theobromins und Caffeïns. Arch Exp Pathol Pharmakol 25: 45–55
Bondzynski S, Gottlieb R (1896) Über die Constitution des nach Coffein und Theobromin im Harne auftretenden Methylxanthins. Arch Exp Pathol Pharmakol 37: 385–388
Bory C, Baltassat P, Porthault M, Bethenod M, Frederich A, Aranda JV (1978) Biotransformation of theophylline to caffeine in premature newborn. Lancet 1204–1205
Bory C, Baltassat P, Porthault M, Bethenod M, Frederich A, Aranda JV (1979) Metabolism of theophylline to caffeine in premature newborn infants. J Pediatr 94: 988–993
Boutroy M-J (1978) Etude de la pharmacologic de la 1,3-dimethylxanthine chez le prématuré. Master’s Thesis, University of Nancy
Boutroy M-J, Vert P, Monin P, Royer RJ, Royer-Morrot M-J (1979 a) Methylation of theophylline to caffeine in premature infants. Lancet 830
Boutroy M-J, Vert P, Royer RJ, Monin P, Royer-Morrot M-J (1979 b) Caffeine, metabolite of theophylline during the treatment of apnea in premature infant. J Pediatr 94: 996–998
Brazier JL, Ribon B, Desage M, Salle B (1980 a) Study of theophylline metabolism in premature human newborns using stable isotope labelling. Biomed Mass Spectrom 7: 189–192
Brazier JL, Salle BL, Ribon B, Renaud H, Desage M (1980 b) Metabolism of theophylline labeled with stable isotopes in the premature newborn infant. Colloq Inst Natl Sante Rech Med (Pharmacol Dev) 89: 309–316
Bresler HW (1904) Über die Bestimmung der Nucleinbasen im Safte von Beta vulgaris. Hoppe Seylers Z Physiol Chem 4: 535–541
Brodie BB, Axelrod J, Reichenthal J (1952) Metabolism of theophylline (1,3-dimethylxanthine) in man. J Biol Chem 194: 215–222
Buchanan OH, Block WD, Christman AA (1945 a) The metabolism of the methylated purines. I. The enzymatic determination of urinary uric acid. J Biol Chem 157: 181–187
Buchanan OH, Christman AA, Block WD (1945 b) The metabolism of the methylated purines. II. Uric acid excretion following the ingestion of caffeine, theophylline and theobromine. J Biol Chem 157: 189–201
Bülow KB, Larsson H (1969) Absorption of orally administered tritium labelled theophylline preparations. Pharmacol Clin 1: 156–160
Burg AW (1975) Physiological disposition of caffeine. Drug Metab Rev 4: 199–228
Burg AW, Stein ME (1972) Urinary excretion of caffeine and its metabolites in the mouse. Biochem Pharmacol 21: 909–922
Burg AW, Werner E (1972) Tissue distribution of caffeine and its metabolites in the mouse. Biochem Pharmacol 21: 923–936
Burg AW, Burrows R, Kensler CJ (1974) Unusual metabolism of caffeine in the squirrel monkey. Toxicol Appl Pharmacol 28: 162–166
Burian R, Schur H (1900) Über die Stellung der Purinkörper im menschlichen Stoffwechsel. Arch Gesamte Physiol 80: 241–343
Butts WC, Mrochek JE, Young DS (1971) Influence of certain components of a chemically defined diet on urinary excretion of ultraviolet-absorbing compounds. Clin Chem 17: 956–957
Caldwell J, Monks TJ, Smith RL (1978) A comparison of the metabolism and pharmacokinetics of intravenously administered theophylline and aminophylline in man. Br J Pharmacol 63: 369P–370P
Caldwell J, Lawrie CA, Monks TJ (1980) The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in man. Br J Pharmacol 70: 111P–112P
Caldwell J, O’Gorman J, Adamson RH (1981) The metabolism of caffeine in three non-human primate species. In: Rietbrock N, Woodcock GB, Staib AH (eds) Methods in clinical pharmacology, vol 3. Vieweg, Braunschweig Wiesbaden, pp 181–185
Callahan MM, Robertson RS, Branfman AR, McComish M, Yesair DW (1980) In: IXth international colloquium on the science and technology of coffee, vol 1. Association Scientifique International du Café, Paris, 1981, pp 371–384
Callahan MM, Robertson RS, Arnaud MJ, Branfman AR, McComish MF, Yesair DW (1982) Human metabolism of [1-methyl-14C] and [2–14C] caffeine after oral administration. Drug Metab Dispos 10: 417–423
Chou C-H, Waller GR (1980) Possible allelopathic constituents of coffea arabica. J Chem Ecol 6: 643–654
Christensen HD, Manion CV, Kling OR (1981) Caffeine kinetics during late pregnancy. In: Soyka LF, Redmond G (eds) Drug metabolism in the immature human. Raven, New York, pp 163–181
Clark GW, de Lorimier AA (1926) The effects of caffeine and theobromine upon the formation and excretion of uric acid. Am J Physiol 77: 491–502
Coombs HI (1927) Studies on xanthine oxidase. IX. The specificity of the system. Biochem J 21: 1259–1265
Cornish HH (1956) A study of the metabolism of theobromine, theophylline and caffeine. University Microfilms, Ann Arbor/Mich, publ no 21, p 165
Cornish HH, Christman AA (1957) A study of the metabolism of theobromine, theophylline and caffeine in man. J Biol Chem 228: 315–323
Daniell WF (1865) On the kola-nut of tropical West Africa (The gurunut of Soudan). Pharm J 6: 450–457
De NC, Mittelman A, Jenkins EE, Grain PF, McCloskey JA, Chheda GB (1980) Isolation of a new modified uracil derivative from huma urine. J Carbohydrates Nucleosides Nucleotides 7: 113–129
De NC, Mittelman A, Dutta SP, Edmonds CG, Jenkins EE, McCloskey JA, Blakley CR, Vestal ML, Chheda GB (1981) Isolation and characterization of two new modified uracil derivates from human urine. J Carbohydrates Nucleosides Nucleotides 8: 363–389
Desmond PV, Patwardhan R, Parker R, Schenker S, Speeg KV Jr (1980) Effect of Cimetidine and other antihistaminics on the elimination of aminopyrine, phenacetin and caffeine. Life Sci 26: 1261–1268
Dictionnaire des termes de médecine, chirurgie, art vétérinaire, pharmacie, histoire naturelle, botanique, physique, chimie, etc. (1823), Paris, p 109
Dixon M (1926) Studies on xanthine oxidase. VII. The specificity of the system. Biochem J 20: 703–718
Fabro S, Sieber SM (1969) Caffeine and nicotine penetrate the preimplantation blastocyst. Nature 223: 410–411
Fechner MGT (1826) Repertorium der organischen Chemie. Leipzig
Ferrero JL, Neims AH (1983) Biotransformation of caffeine by mouse liver microsomes: GSH or cytosol causes a shift in products from 1,3,7-trimethyluric acid to 6-amino-5[N-formylmethylamino]1,3-dimethyluracil (Abstr 5871). Fed Proc 42: 1293
Fink K, Adams WS, Pfleiderer W (1964) A new urinary pyrimidine, 5-acetylamino-6-amino-3-methyluraeil. Its isolation, identification and synthesis. J Biol Chem 239: 4250–4256
Fischer E (1882) Über Caffeïn, Theobromin, Xanthin und Guanin. Liebigs Ann Chem 215: 253–320
Fischer E (1897) Über die Constitution des Caffeïns, Xanthins, Hypoxanthins und verwandter Basen. Ber Dtsch Chem Ges 30: 549–559
Fischer E, Ach L (1895) Synthese des Caffeïns. Ber Dtsch Chem Ges 28: 3135–3143
Grant DM, Tang BK, Kalow W (1983) Polymorphic N-acetylation of a caffeine metabolite. Clin Pharmacol Ther 33: 335–359
Grygiel JJ, Birkett DH (1980) Effect of age on patterns of theophylline metabolism. Clin Pharmacol Ther 28: 456–462
Haig A (1896) Uric acid as a factor in causation of diseases. London
Hess N, Schmoll E (1896) Über die Beziehungen der Eiweiß- und Paranucleinsubstanzen der Nahrung zur Alloxurkörperausscheidung im Harn. Arch Exp Pathol Pharmakol 37: 243–253
Horning MG, Nowlin J, Thenot JP, Bouwsma OJ (1979) Effect of deuterium substitution on the rate of caffeine metabolism. In: Stable Isotopes, Proceedings of 3rd International Conference, 1978, pp 379–384
Jager-Roman E, Doyle PE, Thomas D, Baird-Lambert J, Cvejic M, Buchanan N (1982) Increased theophylline metabolism on premature infants after prenatal betamethasone administration. Dev Pharmacol Ther 5: 127–135
Jenne JW, Nagasawa HT, Thompson RD (1976) Relationship of urinary metabolites of theophylline to serum theophylline levels. Clin Pharmacol Ther 19: 375–381
Jobst C (1838) Thein identisch mit Caffein. Ann Chem Pharm 25: 63–66
Johnson EA (1952) The occurence of substituted uric acids in human urine. Biochem J 51: 133–138
Kamei K, Matsuda M, Momose A (1975) New sulfur-containing metabolites of caffeine. Chem Pharm Bull (Tokyo) 23: 683–685
Kelley WN, Wyngaarden JB (1970) Effect of dietary purine restriction, allopurinol, and oxipurinol on urinary excretion of ultraviolet-absorbing compounds. Clin Chem 16: 707–713
Khanna KL, Rao GS, Cornish HH (1972) Metabolism of caffeine-3H in the rat. Toxicol Appl Pharmacol 23: 720–730
Klinge WE (1981) Method for the separation and quantification of methylated hydroxypurines found in urine of man and its application to the study of human metabolism of methylxanthines. Biochem Soc Trans 9: 120–121
Kossel A (1888) Über eine neue Base aus dem Pflanzenreich. Ber Dtsch Chem Ges 21: 2164–2167
Kotake AN, Schoeller DA, Lambert GH, Baker AL, Schaffer DD, Josephs H (1982) The caffeine CO2 breath test: dose response and route of N-demethylation in smokers and nonsmokers. Clin. Pharmacol Ther 32: 261–269
Krüger M (1899 a) Über den Abbau des Caffeïns im Organismus des Hundes. Ber Chem Ges 32: 2818–2824
Krüger M (1899 b) Über den Abbau des Caffeïns im Organismus des Kaninchens. Ber Chem Ges 32: 3336–3337
Krüger M, Salomon G (1895/1896) Die Constitution des Heteroxanthins und seine physiologischen Wirkungen. Z Physiol Chem 21: 169–185
Krüger M, Salomon G (1898) Die Alloxurbasen des Harnes. Z Physiol Chem 24: 364–394
Krüger M, Salomon G (1898/1899) Die Alloxurbasen des Harnes. Z Physiol Chem 26: 350–380
Krüger M, Schmidt J (1900) Das Verhalten von Theobromin im Organismus des Menschen. Arch Exp Pathol Pharmakol 45: 259–261
Krüger M, Schmidt J (1901) Der Einfluß des Caffeïns und Theobromins auf die Ausscheidung der Purinkörper im Harne. Z Physiol Chem 32: 104–110
Krüger M, Schmidt P (1899) Über das Verhalten von Theobromin, Paraxanthin und 3-Methylxanthin im Organismus. Ber Chem Ges 32: 2677–2682
Latini R, Bonati M, Marzi E, Garattini S (1981) Urinary excretion of an uracilic metabolite from caffeine by rat, monkey and man. Toxicol Lett 7: 267–272
Lehmann CG (1850) Lehrbuch der physiologischen Chemie, 2nd edn. Leipzig, p 367
Leven (1868) Action physiologique et médicamenteuse de la caféine. Arch Physiol Norm Pathol 1: 179–189
Logan L, Kling OR, Christensen HD (1983) Xanthine metabolism in pregnant baboons (Abstr 5870). Fed Proc 42
Lohmann SM, Miech RP (1975) Synthesis and purification of 8–14C-theophylline. J Labelled Compd 11: 515–519
Lohmann SM, Miech RP (1976) Theophylline metabolism by the rat liver microsomal system. J Pharmacol Exp Ther 196: 213–225
Markham R, Smith JD (1949) Chromatographic studies of nucleic acids. 1. A technique for the identification and estimation of purine and pyrimidine bases, nucleosides and related substances. Biochem J 45: 294–298
Martin GJ (1948) The effect of various agents on the excretion of uric acid and allantoin. Exp Med Surg 6: 24–27
Marthas T(1826) Das Guaranin; ein neuer Pflanzenbildungstheil. Arch Gesamte Nat 7: 266–271
Martius T (1840) Über die Zusammensetzung des Guaranins. Ann Chem 36: 93–95
Medicus L (1875) Zur Constitution der Harnsäuregruppe. Liebigs Ann Chem 175: 230–251
Mendel LB, Wardell EL (1917) Effect of ingestion of coffee, tea and caffeine on the excretion of uric acid in man. JAMA 68: 1805–1807
Miners JO, Attwood J, Birkett DJ (1982) Theobromine metabolism in man. Drug Metab Dispos 10: 692–675
Monks TJ, Lawrie CA, Caldwell J (1981) The effect of increased caffeine intake on the metabolism and pharmacokinetics of theophylline in man. Biopharm Drug Dispos 2: 31–37
Morgan EJ, Stewart CP, Hopkins FG (1922) Anaerobic and aerobic oxidation of xanthine and hypoxanthine by tissues and by milk. Proc R Soc Lond [Biol] 94: 109–131
Mrocheck JE, Butts WC, Rainey WT Jr, Burtis CA (1971) Separation and identification of urinary constituents by use of multiple-analytical techniques. Clin Chem 17: 72–77
Muir KT, Jonkman JHG, Tang DS, Kunitani M, Riegelman S (1980) Simultaneous determination of theophylline and its major metabolites in urine by reverse-phase ion-pair HPLC. J Chromatogr 221: 85–95
Mulder CJ (1838) Chemische Untersuchung des chinesischen und des javanischen Thees. Arch Pharm 65: 68–84
Myer VC, Hanzal RF (1929) A study of methyl uric acids. Am J Physiol 90: 458–459
Myers VC, Hanzal RF (1946) The metabolism of methylxanthines and their related methyluric acids. J Biol Chem 162: 309–323
Myers VC, Wardell EL (1928) The influence of the ingestion of methylxanthine on the excretion of uric acid. J Biol Chem 77: 697–722
Oudry V (1827) Thein, eine organische Salzbase im Thee (Thea chinesis). Mag Pharm 19: 49–50
Pelletier MJ (1826) Note sur la caféine. J Pharm 12: 229–233
Pfleiderer W (1971) Synthese und Eigenschaften von 5,6,7,8-Tetrahydroluminazinen und ihren 5-Acetyl-Derivaten. Liebigs Ann Chem 747: 111–222
Pinkard KJ, Cooper IA, Motteram R, Turner CN (1972) Purine and pyrimidine excretion in Hodgkin’s disease. J Natl Cancer Inst 49: 27–38
Rafter JJ, Nilsson L (1981) Involvement of the intestinal microflora in the formation of sulfur-containing metabolites of caffeine. Xenobiotica 11: 771–778
Rao GS, Khanna KL, Cornish HH (1972) Mass spectrometric identification of methylxanthines and methyluric acids, the possible metabolites of caffeine. J Pharm Sci 61: 1822–1825
Rao GS, Khanna KL, Comish HH (1973) Identification of two new metabolites of caffeine in the rat urine. Experientia 19: 953–955
Robiquet (1823) Café. In: Dictionnaire technologique, vol 4. Thomine et Fortic, Paris
Rost E (1895) Über die Ausscheidung des Coffeins und Theobromins im Harn. Arch Exp Pathol Pharmakol 36: 56–71
Rovei V, Chanoine F, Strolin-Benedetti M (1982) Pharmacokinetics of theophylline: a dose-range study. Br J Clin Pharmacol 14: 769–778
Runge F (1820) Phytochemische Entdeckungen. Berlin, p 204
Salomon G (1883) Über das Paraxanthin, einen neuen Bestandtheil des normalen menschlichen Harns. Ber Dtsch Chem Ges 16: 195–200
Salomon G (1885) Über Paraxanthin und Heteroxanthin. Ber Dtsch Chem Ges 18: 3406–3410
Scalais E, Papageorgiou A, Aranda JV (1983) Biotransformation of theophylline during the first six weeks of life (Abstr 409). Pediatr Res 17
Scheele KW (1776) Calculi urinarii. Opuscula 2: 73–79
Schmidt G, Huenisch E (1966) Detection of theobromine and its metabolites in urine. Dtsch Z Gesamte Gerichtl Med 57: 393–401
Schmidt G, Kuehl H (1968) Detection of theophylline and its metabolites in human urine. Wiss Z Martin Luther Univ Halle Wittenberg Math Naturwiss Reihe 17: 553–559
Schmidt G, Schoyerer R (1966) Detection of caffeine and its metabolites in the urine. Dtsch Z Gesamte Gerichtl Med 57: 402–409
Soyka LF, Neese AL (1978) Perinatal exposure to methylxanthines: Possible effects of pregnancy outcome (Abstr). Clin Pharmacol Ther 23: 130
Staib AH, Schuppan D, Lissner R, Zilly W, V Bomhard G, Richter E (1980) Pharmacokinetics and metabolism of theophylline in patients with liver diseases. Int J Clin Pharmacol Ther Toxicol 18: 500–502
Stenhouse J (1843) Über Thein und seine Darstellung. Liebigs Ann Chem 45: 366–372
Strecker A (1861) Untersuchungen über die chemischen Beziehungen zwischen Guanin, Xanthin, Theobromin, Caffeïn und Kreatinin. Liebigs Ann Chem 118: 151–177
Sved S, Wilson DL (1977) Simultaneous assay of the methylxanthine metabolites of caffeine in plasma by high performance liquide chromatography. Res Commun Chem Pathol Pharmacol 17: 319–331
Sved S, Hossie RD, McGilveray IJ (1976) The human metabolism of caffeine to theophylline. Res Commun Chem Pathol Pharmacol 13: 185–192
Tang BK, Grant DM, Kalow W (1983) Isolation and identification of 5-acetylamino-6-formylami-no-3-methyluracil as a major metabolite of caffeine in man. Drug Metab Dispos 11: 218–220
Tang-Liu DD-S, Riegelman S (1981) Metabolism of theophylline to caffeine in adults. Res Commun Chem Pathol Pharmacol 34: 371–380
Tang-Liu DD-S, Riegelman S (1982) An automated HPLC assay for simultaneous quantitation of methylated xanthines and uric acids in urine. J Chromatogr Sci 20: 155–159
Tang-Liu DD-S, Williams RL, Riegelman S (1983) Disposition of caffeine and its metabolites in man. J Pharmacol Exp Ther 224: 180–185
Tse FLS, Szeto DW (1981) Reversed-phase high performance liquid chromatographic determination of caffeine and its N-demethylated metabolites in dog plasma. J Chromatogr 226: 231–236
Tserng K-Y, King C, Takieddine FN (1981) Theophylline metabolism in premature infants. Clin Pharmacol Ther 29: 594–600
Van Gennip AH, de Bree PK, van der Heiden C, Wadman SK, Haverkamp J, Vliegenthart JFG (1973) Urinary excretion of 3-methylxanthine and related compounds in children. Clin Chem Acta 45: 119–127
Van Gennip AH, Grift J, van Bree-Blom EJ, Ketting D, Wadman SK (1979) Urinary excretion of methylated purines in man and in the rat after the administration of theophylline. J Chromatogr 163: 351–362
Von Giese F (1820) Vermischte Notizen. 1. Kaffeestoff und Salzgehalt des Quassia Extrakts. Allg Nord Ann Chem Freunde Naturkd Arzneiwiss 4: 240–241
Warren RN (1969) Metabolism of xanthine alkaloids in man. J Chromatogr 40: 468–469
Warszawski D, Ben-Zvi Z, Gorodischer R, Arnaud MJ, Bracco I (1982) Urinary metabolites of caffeine in young dogs. Drug Metab Dispos 10: 424–428
Weinfeld H (1951) Metabolism of methylxanthines. Fed Proc 10: 267
Weinfeld H, Christman A (1953) The metabolism of caffeine and theophylline. J Biol Chem 200: 345–355
Weissmann B, Bromberg PA, Gutman AB (1954) Chromatographic investigation of purines in normal human urine. Proc Soc Exp Biol Med 87: 257–260
Weissmann B, Bromberg PA, Gutman AB (1957) The purine bases of human urine. II. Semiquantitative estimation and isotope incorporation. J Biol Chem 224: 423–434
Welch RM, Hsu SY, DeAngelis RL (1977) Effect of Aroclor 1254, phenobarbitol and polycyclic aromatic hydrocarbons on the plasma clearance of caffeine in the rat. Clin Pharmacol Ther 22: 791–798
Wietholtz H, Voegelin M, Arnaud MJ, Bircher J, Preisig R (1981) Assessment of the cytochrome P-448 dependent liver enzyme system by a caffeine breath test. Eur J Clin Pharmacol 21: 53–59
Williams JF, Lowitt S, Szentivanyi A (1979) Effect of phenobarbital and 3-methylcholanthrene pre-treatment on the plasma half-life and urinary excretion profile of theophylline and its metabolites in rats. Biochem Pharmacol 28: 2935–2940
Woskresensky A (1842) Über das Theobromin. Liebigs Ann Chem 41: 125–127
Young DS (1970) Effect of a chemically defined diet on urinary excretion of minerals and aromatic compounds. Clin Chem 16: 681–686
Young DS, Epley JA, Goldman P (1971) Influence of a chemically-defined diet on the composition of serum and urine. Clin Chem 17: 765–773
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1984 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Arnaud, M.J. (1984). Products of Metabolism of Caffeine. In: Dews, P.B. (eds) Caffeine. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-69823-1_1
Download citation
DOI: https://doi.org/10.1007/978-3-642-69823-1_1
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-69825-5
Online ISBN: 978-3-642-69823-1
eBook Packages: Springer Book Archive